TRAKMEDIUM SIGNALFINANCIAL10-K

TRAK showed solid operational performance with 24% operating income growth and increased dividend payments, while significantly reducing share buybacks and capital expenditures.

The company demonstrated strong operational execution with meaningful increases in profitability and cash generation, supporting a 10% dividend increase. However, the 87% reduction in share buybacks and 78% decline in capital expenditures may signal either improved capital discipline or reduced investment in growth initiatives that investors should monitor.

Comparing 2025-09-29 vs 2024-09-30View on EDGAR →
FINANCIAL ANALYSIS

TRAK delivered strong financial performance with operating income growing 24% to $6.2M and operating cash flow increasing 21% to $8.4M, resulting in improved cash reserves of $24.1M. The company significantly scaled back capital allocation activities, reducing share buybacks by 87% to $200K and cutting capital expenditures by 78% to $16K. Total liabilities increased 23% to $5.8M, but this appears manageable given the strong cash position and improved profitability, with the overall picture suggesting a company prioritizing cash preservation while maintaining solid operational momentum.

FINANCIAL STATEMENT CHANGES
Share Buybacks
Cash Flow
-86.8%
$1.5M→$200K

Buyback activity reduced 86.8% — capital being redeployed elsewhere or cash conservation underway.

Capital Expenditure
Cash Flow
-78.2%
$73K→$16K

Capex reduced 78.2% — investment cycle winding down or capital discipline; may improve near-term free cash flow.

Interest Expense
P&L
+37.7%
$44K→$61K

Interest expense surged 37.7% — significant debt increase or rising rates materially impacting earnings.

Operating Income
P&L
+23.9%
$5.0M→$6.2M

Operating income improving — cost discipline or growing revenue base absorbing fixed costs.

Total Liabilities
Balance Sheet
+22.5%
$4.7M→$5.8M

Liabilities increased 22.5% — monitor debt-to-equity ratio and interest coverage.

Current Liabilities
Balance Sheet
+21.7%
$4.5M→$5.5M

Current liabilities rose 21.7% — increased short-term obligations, watch current ratio.

Operating Cash Flow
Cash Flow
+20.9%
$7.0M→$8.4M

Operating cash flow grew 20.9% — strong conversion of earnings to cash, healthy business fundamentals.

Cash & Equivalents
Balance Sheet
+18.3%
$20.3M→$24.1M

Cash grew 18.3% — improving liquidity position supports investment and shareholder returns.

Net Income
P&L
+17.1%
$6.0M→$7.0M

Net income grew 17.1% — bottom-line growth signals improving overall business health.

Current Assets
Balance Sheet
+15%
$29.3M→$33.7M

Current assets grew 15% — improving short-term liquidity or inventory/receivables build.

LANGUAGE CHANGES
NEW — 2025-09-29
PRIOR — 2024-09-30
ADDED
true false false false false true 242,437 227,573 0.01 0.01 30,000,000 30,000,000 700,000 700,000 336,098 336,098 616,470 616,470 0.01 0.01 50,000,000 50,000,000 18,282,805 18,282,805 18,234,893 18,234,893 2 3 3 3 3 3 311,450 0 0 http://fasb.org/us-gaap/2025#SecuredOvernightFinancingRateSofrMember 3 3 3 3 0 0 5 0 3 10.70 336,098 0 0 1 Contract asset balances for June 30, 2025 include a current and a long-term contract asset of $428,585 and $0, respectively.
As of September 29, 2025, 18,283,903 shares of the Company s common stock, par value $0.01 per share, were outstanding.
Recent Developments Dividend Payment On June 20, 2025, the Board of Directors of ReposiTrak, Inc.
(the Company ) declared a quarterly cash dividend of $0.01815 per share ($0.0726 per year), payable to shareholders of record on June 30, 2025, which was paid to shareholders of record on or about August 14, 2025.
Based on the closing prices on June 30, 2025, this represented an annual dividend yield of approximately 0.37%.
+7 more — sign up free →
REMOVED
Fields Chairman and Chief Executive Officer true 227,573 170,103 0.01 0.01 30,000,000 30,000,000 700,000 700,000 616,470 616,470 625,375 625,375 550,000 550,000 0 0 212,402 212,402 0.01 0.01 50,000,000 50,000,000 18,234,893 18,234,893 18,309,051 18,309,051 2 3 3 3 3 10,000 0 http://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrMember 3 3 3 0 0 no 5 0 3 10.70 616,470 0 0 0 0 Contract asset balances for June 30, 2024 include a current and a long-term contract asset of $181,680 and $108,052, respectively.
As of September 30, 2024, 18,246,089 shares of the Company s common stock, par value $0.01 per share, were outstanding.
Transfer of Listing from NASDAQ to NYSE The Company filed a Registration Statement on Form 8-A in connection with the transfer of the listing of its common stock, par value $0.01 per share ( Common Stock ), from the Nasdaq Capital Market of The Nasdaq Stock Market LLC ( Nasdaq ) to the New York Stock Exchange (the NYSE ).
The Company commenced the trading of its Common Stock on the NYSE on November 2, 2023 under the symbol TRAK.
Trading on the Nasdaq Capital Market ceased concurrently with the NYSE listing.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
PNRGHIGHPNRG achieved exceptional profitability improvement with net income surging 2,21...
2026-04-16
BNAIHIGHBNAI underwent a dramatic reverse stock split that reduced share count by 86% wh...
2026-04-16
LAKEHIGHLAKE's financial performance deteriorated significantly with operating losses wo...
2026-04-16
NXXTHIGHNextNRG experienced massive financial deterioration with operating losses explod...
2026-04-16
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →